CTLA4 and neoplasm: When the CTLA-4 ligands CD80 and CD86 or the PD-1 ligand PDL-1 are expressed by tumor cells, they effectively inhibit activation of cytotoxic T-cells and foster escape from recognition and elimination by the immune system [65,136,137,138,139].